Physician profile
Frank Noto
NPI 1134232176
$15,590.02
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $688 · 2020: $11K · 2021: $1,666 · 2022: $851 · 2023: $1,594 · 2024: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,883.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,882.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $10,967.04 | 2019-2021 | |
| Nevro Corp. | $947.12 | 2020-2024 | Senza |
| Intuity Medical INC | $523.93 | 2022-2023 | Pogo Automatic Blood Glucose Monitoring System |
| Mannkind Corporation | $506.70 | 2022-2023 | Afrezza |
| Abbott Laboratories | $341.56 | 2020-2023 | Proclaim, Freestyle Libre 2 |
| Abbvie INC. | $339.63 | 2020-2021 | |
| Amryt Pharma Holdings LTD | $200.40 | 2023 | Mycapssa |
| Zealand Pharma US, INC. | $181.01 | 2020-2021 | |
| Amgen INC. | $173.02 | 2020 | |
| Cequr Corporation | $161.17 | 2023 | Cequr Simplicity |
| Intra-Sana Laboratories | $150.00 | 2024 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Biohaven Pharmaceuticals, INC. | $150.00 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $147.50 | 2022 | |
| Nestle Healthcare Nutrition INC. | $125.00 | 2021 | |
| Chiasma, INC. | $125.00 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $124.97 | 2022 | |
| Gilead Sciences, INC. | $124.89 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $120.31 | 2023 | Breztri |
| Corcept Therapeutics | $100.02 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $45.31 | 2019-2020 | |
| Pfizer INC. | $18.54 | 2022 | |
| Sanofi Pasteur INC. | $16.90 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Noto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.